セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/20 | 1,429 | 1,442 | 1,406 | 1,419 | -1 | -0.1% | 68,100 |
| 2024/05/17 | 1,399 | 1,421 | 1,382 | 1,420 | +16 | +1.1% | 74,700 |
| 2024/05/16 | 1,436 | 1,436 | 1,402 | 1,404 | -28 | -2% | 55,400 |
| 2024/05/15 | 1,490 | 1,490 | 1,432 | 1,432 | -59 | -4% | 57,800 |
| 2024/05/14 | 1,444 | 1,491 | 1,444 | 1,491 | +54 | +3.8% | 52,600 |
| 2024/05/13 | 1,416 | 1,447 | 1,416 | 1,437 | +15 | +1.1% | 59,200 |
| 2024/05/10 | 1,496 | 1,502 | 1,417 | 1,422 | -67 | -4.5% | 138,200 |
| 2024/05/09 | 1,528 | 1,536 | 1,481 | 1,489 | -13 | -0.9% | 87,300 |
| 2024/05/08 | 1,527 | 1,554 | 1,502 | 1,502 | -25 | -1.6% | 67,200 |
| 2024/05/07 | 1,520 | 1,547 | 1,514 | 1,527 | +16 | +1.1% | 56,400 |
| 2024/05/02 | 1,546 | 1,549 | 1,507 | 1,511 | -36 | -2.3% | 47,100 |
| 2024/05/01 | 1,568 | 1,568 | 1,502 | 1,547 | -12 | -0.8% | 88,000 |
| 2024/04/30 | 1,540 | 1,573 | 1,522 | 1,559 | +37 | +2.4% | 149,200 |
| 2024/04/26 | 1,509 | 1,556 | 1,497 | 1,522 | +5 | +0.3% | 216,300 |
| 2024/04/25 | 1,525 | 1,567 | 1,497 | 1,517 | -9 | -0.6% | 103,700 |
| 2024/04/24 | 1,536 | 1,549 | 1,513 | 1,526 | +6 | +0.4% | 61,000 |
| 2024/04/23 | 1,534 | 1,544 | 1,477 | 1,520 | +2 | +0.1% | 89,500 |
| 2024/04/22 | 1,497 | 1,523 | 1,478 | 1,518 | +51 | +3.5% | 111,900 |
| 2024/04/19 | 1,533 | 1,535 | 1,464 | 1,467 | -84 | -5.4% | 176,500 |
| 2024/04/18 | 1,467 | 1,572 | 1,467 | 1,551 | +98 | +6.7% | 172,400 |
| 2024/04/17 | 1,541 | 1,542 | 1,453 | 1,453 | -88 | -5.7% | 125,500 |
| 2024/04/16 | 1,550 | 1,595 | 1,535 | 1,541 | -5 | -0.3% | 198,800 |
| 2024/04/15 | 1,503 | 1,553 | 1,486 | 1,546 | +73 | +5% | 155,500 |
| 2024/04/12 | 1,477 | 1,510 | 1,465 | 1,473 | +5 | +0.3% | 96,100 |
| 2024/04/11 | 1,440 | 1,478 | 1,431 | 1,468 | +22 | +1.5% | 83,200 |
| 2024/04/10 | 1,498 | 1,507 | 1,445 | 1,446 | -59 | -3.9% | 180,700 |
| 2024/04/09 | 1,509 | 1,544 | 1,493 | 1,505 | +18 | +1.2% | 140,600 |
| 2024/04/08 | 1,467 | 1,527 | 1,449 | 1,487 | +39 | +2.7% | 172,300 |
| 2024/04/05 | 1,435 | 1,458 | 1,418 | 1,448 | +8 | +0.6% | 131,700 |
| 2024/04/04 | 1,425 | 1,458 | 1,407 | 1,440 | +26 | +1.8% | 141,500 |
| 2024/04/03 | 1,381 | 1,424 | 1,367 | 1,414 | +3 | +0.2% | 80,800 |
| 2024/04/02 | 1,438 | 1,445 | 1,398 | 1,411 | -27 | -1.9% | 119,800 |
| 2024/04/01 | 1,471 | 1,484 | 1,438 | 1,438 | -7 | -0.5% | 97,800 |
| 2024/03/29 | 1,488 | 1,509 | 1,424 | 1,445 | -42 | -2.8% | 147,900 |
| 2024/03/28 | 1,450 | 1,525 | 1,450 | 1,487 | +35 | +2.4% | 137,000 |
| 2024/03/27 | 1,476 | 1,482 | 1,448 | 1,452 | -30 | -2% | 92,800 |
| 2024/03/26 | 1,414 | 1,483 | 1,393 | 1,482 | +56 | +3.9% | 143,300 |
| 2024/03/25 | 1,372 | 1,450 | 1,372 | 1,426 | +47 | +3.4% | 214,500 |
| 2024/03/22 | 1,386 | 1,386 | 1,343 | 1,379 | -10 | -0.7% | 186,700 |
| 2024/03/21 | 1,430 | 1,445 | 1,380 | 1,389 | -30 | -2.1% | 220,200 |
| 2024/03/19 | 1,445 | 1,463 | 1,406 | 1,419 | -32 | -2.2% | 115,000 |
| 2024/03/18 | 1,461 | 1,502 | 1,445 | 1,451 | +39 | +2.8% | 185,700 |
| 2024/03/15 | 1,469 | 1,469 | 1,398 | 1,412 | -54 | -3.7% | 172,500 |
| 2024/03/14 | 1,416 | 1,507 | 1,415 | 1,466 | +55 | +3.9% | 350,900 |
| 2024/03/13 | 1,469 | 1,496 | 1,355 | 1,411 | -88 | -5.9% | 538,400 |
| 2024/03/12 | 1,387 | 1,650 | 1,381 | 1,499 | +94 | +6.7% | 1,317,200 |
| 2024/03/11 | 1,499 | 1,525 | 1,380 | 1,405 | -35 | -2.4% | 288,000 |
| 2024/03/08 | 1,411 | 1,467 | 1,403 | 1,440 | +20 | +1.4% | 237,700 |
| 2024/03/07 | 1,508 | 1,520 | 1,410 | 1,420 | -80 | -5.3% | 340,400 |
| 2024/03/06 | 1,437 | 1,539 | 1,430 | 1,500 | +121 | +8.8% | 497,200 |
1～
50
件表示中 / 1112件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 141,900円 | +19.0% | -13.1% | 0.35% | 39.09倍 | 4.57倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| サンバイオ | 46,300円 | - | - | 0.00% | - | 12.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ステムリム | 46,500円 | -14.9% | -31.0% | 0.00% | 190.57倍 | 3.34倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| クオリプス | 323,000円 | -13.0% | - | 0.00% | - | 4.30倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| 扶桑薬 | 228,700円 | +2.9% | +23.1% | 3.50% | 11.50倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム
